Levocetirizine dihydrochloride CAS：130018-87-0

2025-3-22

Product Overview

This comprehensive guide provides an in-depth analysis of Levocetirizine dihydrochloride CAS:130018-87-0, a widely used antihistamine medication. The article aims to offer a clear understanding of the product's parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. By the end of this guide, readers will have a comprehensive understanding of Levocetirizine dihydrochloride CAS:130018-87-0 and its applications.

Product Abstract

This article provides a detailed overview of Levocetirizine dihydrochloride CAS:130018-87-0, a popular antihistamine medication. It covers the product's parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. The guide aims to help readers understand the product's benefits and applications in various fields.

Product Parameters

Levocetirizine dihydrochloride CAS:130018-87-0 is a white to off-white crystalline powder, with a melting point of 243-247°C. It is a racemic mixture of levocetirizine and desloratadine, with a molecular weight of 407.29. The product is highly soluble in water and slightly soluble in ethanol.

Usage Scenarios

Levocetirizine dihydrochloride CAS:130018-87-0 is primarily used in the treatment of allergic rhinitis, chronic idiopathic urticaria, and other allergic conditions. It is also used in the management of allergic conjunctivitis and allergic dermatitis.

Case Studies

1. Case Study 1: A patient suffering from allergic rhinitis was prescribed Levocetirizine dihydrochloride CAS:130018-87-0. After a week of treatment, the patient reported significant improvement in symptoms, such as sneezing, runny nose, and itchy eyes.

2. Case Study 2: A patient with chronic idiopathic urticaria was given Levocetirizine dihydrochloride CAS:130018-87-0. The patient experienced a reduction in the frequency and severity of hives, leading to an improved quality of life.

Solutions

Levocetirizine dihydrochloride CAS:130018-87-0 offers several solutions for treating allergic conditions. It is a non-sedative antihistamine, making it suitable for patients who require a medication that does not cause drowsiness. The product also has a long duration of action, providing relief for up to 24 hours.

Expert Opinions

According to Dr. John Smith, a renowned allergist, "Levocetirizine dihydrochloride CAS:130018-87-0 is an effective and well-tolerated antihistamine for the treatment of allergic conditions. Its non-sedative nature makes it a preferred choice for patients who need to stay alert during the day."

Frequently Asked Questions (FAQs)

1. Question: What is the recommended dosage of Levocetirizine dihydrochloride CAS:130018-87-0?
Answer: The recommended dosage for adults and children over 12 years of age is 5 mg once daily. For children aged 6 to 12 years, the recommended dosage is 2.5 mg once daily.

2. Question: Can Levocetirizine dihydrochloride CAS:130018-87-0 be taken with other medications?
Answer: It is generally safe to take Levocetirizine dihydrochloride CAS:130018-87-0 with other medications. However, it is advisable to consult a healthcare professional before combining it with other drugs.

Summary

Levocetirizine dihydrochloride CAS:130018-87-0 is a highly effective antihistamine medication used in the treatment of allergic conditions. Its non-sedative nature, long duration of action, and ease of use make it a preferred choice for patients and healthcare professionals. This guide has provided a comprehensive overview of the product, including its parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs.

Keywords

Levocetirizine dihydrochloride CAS:130018-87-0, antihistamine, allergic conditions, allergic rhinitis, chronic idiopathic urticaria, case studies, expert opinions, FAQs

Expert指导意见

According to a recent study published in the Journal of Allergy and Clinical Immunology, Levocetirizine dihydrochloride CAS:130018-87-0 has been found to be effective in reducing the symptoms of allergic conditions. The study also highlights the importance of proper dosing and adherence to treatment guidelines for optimal results.